THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 11th, 2015 • Ophthotech Corp. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2015 Company Industry JurisdictionThis Third Amended and Restated Employment Agreement (the “Agreement”) is made and entered into this April 30, 2015 (the “Effective Date”), by and between Ophthotech Corporation (“Company”), and Samir Patel, M.D. (“Executive”).
AMENDMENT NO. 2 TO THE LICENSE, MANUFACTURING AND SUPPLY AGREEMENTAnd Supply Agreement • May 11th, 2015 • Ophthotech Corp. • Pharmaceutical preparations
Contract Type FiledMay 11th, 2015 Company IndustryThis Amendment No. 2 to the License, Manufacturing and Supply Agreement (this “Amendment”) by and between Nektar Therapeutics, a Delaware corporation with offices at 455 Mission Bay Boulevard South, San Francisco, California 94158 (“Nektar”), successor by merger to Nektar Therapeutics AL, Corporation, an Alabama corporation, and Ophthotech Corporation, a Delaware corporation with offices at One Penn Plaza, Suite 1924, New York, NY 10119 (“Ophthotech”) is effective as of February 11th, 2015 (“Effective Date of Amendment No. 2”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the License, Manufacturing and Supply Agreement (the “Agreement”) made effective as of September 30, 2006 by and between Nektar and (OSI) Eyetech, Inc. (“OSI”), as amended by the Amendment No. 1 to the Agreement effective as of April 5, 2012 by and between Nektar and Ophthotech. Effective July 27, 2007, OSI assigned to Ophthotech all of OSI’s right, title an